Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Thoughts on subjects raised today...ignited

RE: Thoughts on subjects raised today...ignited

posted on May 09, 2006 08:38AM

I believe TPL will continue to work for PTSC. Yep, there is the obvious conflict of negotiated deals which can include non-PTSC product in one form or another. Those are the deals we may never know about. However, TPL is carrying the weight of the very expensive research and they deserve their fair share, IMO. One time rivals do make for interesting bed mates. My guess is TPL could have told PTSC to ``stick it`` when requested to attend and and present at the ASM. They did not. Maybe they own a share or two. Maybe they are just professionals. I doubt we will ever know the answer.

As for long term, you may have a good point -- what happens once TPL wants to stear it`s biz model in another direction? It could happen. My guess -- make that a WAG -- is that once TPL has a dialed in presentation on the beauty of buying a license vs. going to court (cost of licesnse vs cost + risk of litigation and all that); I believe TPL will want to make as many of those presentations as possible. As one who has sold OEM deals that include licenses, I know it gets much easier once you know what buttons to push with a specific potential customer. My guess is TPL is pretty good at what they do or we would not have already received the fruits of their labor with much more anticipated.

If all goes the way TPL wants, the revenue stream could be ongoing for quite some time -- even if TPL moves their primary focus elsewhere.

Of course, all IMO.

John

Share
New Message
Please login to post a reply